Friday, May 26, 2017
Project co-funded by the European Commission in the framework of the 2nd Health Programme
Enter Title Minimize

A.8. BIOVIGILANCE

  • A.8.1. SERIOUS ADVERSE EVENTS/REACTIONS
  • A.8.2. NOTIFICATION OF SERIOUS ADVERSE REACTIONS (RECIPIENTS)
  • A.8.3. NOTIFICATION OF SERIOUS ADVERSE REACTIONS (LIVING DONORS)
  • A.8.4. NOTIFICATION OF SERIOUS ADVERSE EVENTS
Print  
A3f Engine ::Terms Of Use::Privacy Statement